Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)
NCT06838962
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Immune Thrombocytopenia
Treatment
Interventions
DRUG:
Daratumumab Injection
Sponsor
Institute of Hematology & Blood Diseases Hospital, China